"Cancer Research SA (CRSA) seeks to provide compassionate, state-of-the-art care for the cancer patient, accomplishing this through research, education and clinical practice."

During the past decade, Cancer Research SA conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 13 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Cancer Research SA" #1 sponsor was "BeiGene" with 1 trials, followed by "BioAtla, Inc." with 1 trials sponsored, "Eli Lilly and Company" with 1 trials sponsored, "Gilead Sciences" with 1 trials sponsored and "Hanmi Pharmaceutical Company Limited" with 1 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Cancer Research SA" #1 collaborator was "Amgen" with 1 trials as a collaborator, "National Cancer Institute (NCI)" with 1 trials as a collaborator and "Tigermed Consulting Co., Ltd" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Cancer Research SA" are "Advanced Solid Tumor" (2 trials), "Gastric Cancer" (2 trials), "Non Small Cell Lung Cancer" (2 trials), "Ovarian Cancer" (2 trials) and "Small Cell Lung Cancer" (2 trials). Many other conditions were trialed in "Cancer Research SA" in a lesser frequency.

Most popular intervention types in "Cancer Research SA" are "Drug" (12 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Fulvestrant" (2 trials), "6-Thio-2'-Deoxyguanosine" (1 trials), "AMT-151" (1 trials), "Abemaciclib" (1 trials) and "Amivantamab Intravenous" (1 trials). Other intervention names were less common.

The vast majority of trials in "Cancer Research SA" are 13 trials for "All" genders.

Currently, there are NaN active trials in "Cancer Research SA". undefined are not yet recruiting, 13 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Cancer Research SA, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Cancer Research SA, 8 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".